Apex Healthcare products
KUALA LUMPUR: AmInvestment Bank Research has initiated coverage on Apex Healthcare Bhd
with a "buy" recommendation.
The research house has a fair value of RM3.82 a share on the stock, based on a price-earnings of 26x on FY22 forecast earnings per share, which is slightly higher than the regional pharmaceutical industry's average PE of 24.4x for FY22.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
